Dark

ADAP
Adaptimmune Therapeutics plc
stock NASDAQ ADR

At Close

Aug 15, 2025 3:59:30 PM EDT

0.0596USD-18.244%(-0.0133)40,066,772

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Aug 15, 2025 9:28:30 AM EDT

0.0715USD-1.920%(-0.0014)493,247

After-hours

Aug 15, 2025 4:58:30 PM EDT

0.0710USD+19.128%(+0.0114)6,910,503

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

15.76M

Headquarters

Abingdon, Oxfordshire, United Kingdom

Industry

Biotechnology

Next Earnings

Nov 5, 2025 (81d)

NVAX SGMO ENZ QURE XLV

ADAP Stats

Avg. Vol. 10 Day

78,790,770

Avg. Vol. 30 Day

38,515,817

Employees

534

Market Cap

15,757,317

Shares Out.

265,051,591

On/Off Exchange

48%/52%

6 Month Beta

1.04

1 Year Beta

1.00

2 Year Beta

1.12

3 Year Beta

1.11

52 Week Low

0.06

52 Week High

1.33

SMA50

0.21

SMA200

0.42

1 Week

-23.29%

1 Month

-77.98%

3 Month

-78.61%

6 Month

-89.79%

1 Year

-94.50%

2 Year

-92.35%

5 Year

-99.33%

Profile

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

ADAP Stock Summary

Adaptimmune Therapeutics plc (NASDAQ:ADAP) stock price today is $0.0596, and today's volume is 40,066,772. ADAP is down -18.244% today. The 30 day average volume is 38,515,817. ADAP market cap is 15.76M with 265,051,591 shares outstanding.